The frequent dysregulation of PKC isoforms observed in many cancers, and the evidence that PKC plays an important role in cell transformation, differentiation, migration, and tumor progression, has generated considerable interest in the development of specific PKC modulators for cancer treatment [10,15,133]. Here, PRRT2 is linked to cancer.